Table 1.
Clinical data | No. (%) or median (range) | Clinical data | No. (%) or median (range) |
---|---|---|---|
Age, years | 48 (34-75) | TNM stage | |
Sex | III | 12 (37.5) | |
Male | 24 (75.0) | IV | 20 (62.5) |
Female | 8 (25.0) | KPS score | |
Histologic type | ≥80 | 22 (68.8) | |
SCC | 29 (90.6) | <80 | 10 (31.2) |
Adenocarcinoma | 2 (6.3) | Previous treatment | |
Undifferentiated | 1 (3.1) | Surgery | 8 (25.0) |
Location | Radical rsct | 6 (18.8) | |
Cervical | 6 (18.8) | Palliative rsct | 2 (6.3) |
Thoracic (upper) | 9 (28.1) | Radiotherapy | 20 (62.5) |
Thoracic (middle) | 11 (34.4) | PORT | 6 (18.8) |
Thoracic (lower) | 6 (18.8) | Definitive RT | 10 (31.3) |
Length(cm) | Palliative RT | 4 (12.5) | |
≤4 | 10 (31.2) | Chemotherapy | 17 (53.1) |
>4, ≤6 | 16 (50.0) | Induction | 2 (6.3) |
>6 | 6 (18.8) | Concurrent | 6 (18.8) |
Presenting symptoms | Adjuvant | 9 (28.1) | |
Dysphagia | 32 (100) | PDT cycle | |
Pain | 15 (46.9) | 1 | 27 (84.4) |
Cough | 10 (31.2) | 2 | 4 (12.5) |
Sonar | 2 (6.3) | 3 | 1 (3.1) |
Abbreviations: KPS, Karnofsky Performance Status; PDT, photodynamic therapy; PORT, postoperative radiotherapy; Rsct, resection; RT, radiotherapy; SCC, squamous cell carcinoma.